KD can affect tumor cell growth by lowering insulin and IGF-1 levels, thereby reducing receptor tyrosine kinase-dependent signaling pathways such as PI3K-Akt-mTOR for tumor cell proliferation and tumor growth (Figure 5A) [154,158,171,176]. This evidence concerns the gene MTOR and neoplasm.